Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs

References

• Radtke M. Pure drug nanoparticles for the formulation of poorly soluble drugs. New Drugs 2001; 3: 62–68
   Google Scholar
• Lipinski C. Poor aqueous solubility—an industry wide problem in drug delivery. Am. Pharm. Rev. 2002; 5: 82–85
   Google Scholar
• Noyes A. A., Whitney W. R. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc. 1897; 19: 930–934
   Google Scholar
• Tom J. W., Bebenedetti P. G. Particle formation with supercritical fluids—a review. J. Aerosol Sci. 1991; 22: 555–584
   Web of Science ®Google Scholar
• Rogers T. L., Johnston K. P., Williams R. O. A comprehensive review: solution‐based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray‐freezing technologies. Drug Dev. Ind. Pharm. 2001; 27: 1003–1015, [CSA]
   PubMed Web of Science ®Google Scholar
• Pace S. N., Pace G. W., Parikh I., Mishra A. K. Novel injectable formulations of insoluble drugs. Pharm. Technol. 1999; 3: 116–134
   Google Scholar
• Dressman J. B., Reppas C. In vitro‐in vivo correlation for lipophilic, poorly water‐soluble drugs. Eur. J. Pharm. Sci. 2000; 11: S73–S80
   PubMed Web of Science ®Google Scholar
• Serajuddin A. T.M. Solid dispersion of poorly water‐soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 1999; 88: 1058–1066
   PubMed Web of Science ®Google Scholar
• Merisko‐Liversidge E., Liversidge G. G., Cooper E. R. Nanosizing: a formulation approach for poorly‐water‐soluble compounds. Eur. J. Pharm. Sci. 2003; 18: 113–120, [CSA]
   PubMed Web of Science ®Google Scholar
• York P. Strategies for particle design using supercritical fluid technologies. PSTT 1999; 2: 430–440, [CSA]
   PubMedGoogle Scholar
• Cavalli R., Gasco M. R., Barresi A. A., Rovero G. Evaporative drying of aqueous dispersions of solid lipid nanoparticles. Drug Dev. Ind. Pharm. 2001; 27: 919–924, [CSA]
   PubMed Web of Science ®Google Scholar
• Rambali B., Verreck G., Baert L., Massart D. L. Itraconazole formulation studies of the melt‐extrusion process with mixture design. Drug Dev. Ind. Pharm. 2003; 29: 641–652, [CSA]
   PubMed Web of Science ®Google Scholar
• Santhi K., Dhanaraj S. A., Rajendran S. D., Raja K., Ponnusankar S., Suresh B. Nonliposomal approach—a study of preparation of egg albumin nanospheres containing amphotericin‐B. Drug Dev. Ind. Pharm. 1999; 25: 547–551, [CSA]
   PubMed Web of Science ®Google Scholar
• Cherian A. K., Rana A. C., Jain S. K. Self‐assembled carbohydrate‐stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Dev. Ind. Pharm. 2000; 26: 459–463, [CSA]
   PubMed Web of Science ®Google Scholar
• Muller R. H., Peters K. Nanosuspensions for the formulation of poorly soluble drugs I. Preparation by a size‐reduction technique. Int. J. Pharm. 1998; 160: 229–237
   Web of Science ®Google Scholar
• Subramaniam B., Rajewski R. A., Snavely K. Pharmaceutical processing with supercritical carbon dioxide. J. Pharm. Sci. 1997; 86: 885–890
   PubMed Web of Science ®Google Scholar
• Rojanapanthu P., Sarisuta N., Chaturon K., Kraisintu K. Physicochemical properties of amphotericin b liposomes prepared by reverse‐phase evaporation method. Drug Dev. Ind. Pharm. 2003; 29: 31–37, [CSA]
   PubMed Web of Science ®Google Scholar
• Delie F. Evaluation of nano‐ and microparticle uptake by the gastrointestinal tract. Adv. Drug Deliv. Rev. 1998; 34: 221–233, [CSA]
   PubMed Web of Science ®Google Scholar
• Hoffart V., Ubrich N., Simonin C., Babak V., Vigneron C., Hoffman M., Lecompte T., Maincent P. Low molecular weight heparin‐loaded polymeric nanoparticles: formulation, characterization, and release characteristics. Drug Dev. Ind. Pharm. 2002; 28: 1091–1099, [CSA]
   PubMed Web of Science ®Google Scholar
• Brigger I., Dubernet C., Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 2002; 54: 631–651, [CSA]
   PubMed Web of Science ®Google Scholar
• Muller R. H., Jacobs C., Kayser O. Nanosuspension as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 2001; 47: 3–19, [CSA]
   PubMed Web of Science ®Google Scholar
• Pratsinis S. E., Vemury S. Particle formation in gases: a review. Powder Technol. 1996; 88: 267–273
   Web of Science ®Google Scholar
• Müller R. H., Radtke M., Wissing S. A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 2002; 54: S131–S155
   PubMed Web of Science ®Google Scholar
• Soppimath K. S., Aminabhavi T. M., Kulkarni A. R., Rudzinski W. E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 2001; 70: 1–20, [CSA]
   PubMed Web of Science ®Google Scholar
• Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003; 55: 329–347, [CSA]
   PubMed Web of Science ®Google Scholar
• York P., Shekunov B. Y. Crystallization processes in pharmaceutical technology and drug delivery design. J. Cryst. Growth 2000; 211: 122–136
   Web of Science ®Google Scholar
• Liversidge G. G., Cundy K. C., Bishop J. F., Czekai D. A. Surface Modified Drug Nanoparticles. US Patent 5,145,684, 1992
   Google Scholar
• Muller R. H., Becker R., Kruss B., Peters K. Pharmaceutical Nanosuspensions for Medicament Administration as Systems with Increased Saturation Solubility and Rate of Solution. US Patent 5,858,410, 1999
   Google Scholar
• Liversidge G. G. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int. J. Pharm. 1995; 125: 309–313
   Web of Science ®Google Scholar
• Merisko‐Liversidge E., Sarpotdar P., Bruno J., Hajj S., Wei L., Peltier N., Rake J., Shaw J. M., Pugh S., Polin L., Jones J., Corbett T., Cooper E., Liversidge G. G. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm. Res. 1996; 13: 272–278
   PubMed Web of Science ®Google Scholar
• Liversidge G. G., Cundy K. C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 1995; 125: 91–97
   Web of Science ®Google Scholar
• Zheng J. Y. Sterile filtration of nanocrystal drug formulations. Drug Dev. Ind. Pharm. 1997; 23: 1087–1093, [CSA]
   Web of Science ®Google Scholar
• Rawlins E. A. Bentley's Textbook of Pharmaceutics8th Ed. Bailliere Tindall, LondonUK 1977
   Google Scholar
• Bodmeier R., Wang H., Dixon D. J., Mawson S., Johnston K. P. Polymeric microspheres prepared by spraying into compressed carbon dioxide. Pharm. Res. 1995; 12: 1211–1217
   PubMed Web of Science ®Google Scholar
• Hu J., Rogers T. L., Brown J. N., Young T. J., Johnston K. P., Williams R. O. Improvement of dissolution rates of poorly water soluble APIs using the novel spray freezing into liquid technology. Pharm. Res. 2002; 19: 1278–1284
   PubMed Web of Science ®Google Scholar
• Dixon D. J., Johnston K. P., Brodemier R. A. Polymeric materials formed by precipitation with a compressed fluid antisolvent. AIChE J. 1993; 39: 127–139, [CSA]
   Web of Science ®Google Scholar
• Reverchon E., Porta G. D. Production of antibiotic micro‐ and nano‐particles by supercritical antisolvent precipitation. Powder Technol. 1999; 106: 23–29, [CSA]
   Web of Science ®Google Scholar
• Chattopadhyay P., Gupta R. B. Protein nanoparticles formation by supercritical antisolvent with enhanced mass transfer. AIChE J. 2002; 48: 235–244
   Web of Science ®Google Scholar
• Turk M., Hils P., Helfgen B., Schaber K., Martin H. J., Wahl M. A. Micronization of pharmaceutical substances by the rapid expansion of supercritical solutions (RESS): a promising method to improve bioavailability of poorly soluble pharmaceutical agents. J. Supercrit. Fluids 2002; 22: 75–84
   Web of Science ®Google Scholar
• Falk R., Randolph T. W., Meyer J. D., Kelley R. M., Manning M. C. Controlled release of ionic compounds from poly(L‐lactide) microspheres produced by precipitation with a compressed antisolvent. J. Control. Release 1997; 44: 77–85
   Web of Science ®Google Scholar
• Hanna M. H., York P. Method and Apparatus for the Formation of Particles. U.S. Patent 5,851,453, 1998
   Google Scholar
• Steckel H., Müller B. W. Metered‐dose inhaler formulation of fluticasone‐17‐propionate micronized with supercritical carbon dioxide using the alternative propellant HFA‐227. Int. J. Pharm. 1998; 173: 25–33
   Web of Science ®Google Scholar
• Subramaniam B., Saim S., Rajewski R. A., Stella V. Method of Particle Precipitation and Coating Using Nearcritical and Supercritical Antisolvents. U.S. Patent 5,833,891, 1997
   Google Scholar
• Young T. J., Johnston K. P., Mishima K., Tanaka H. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor‐over‐liquid antisolvent. J. Pharm. Sci. 1999; 88: 640–650
   PubMed Web of Science ®Google Scholar
• Young T. J., Mawson S., Johnston K. P., Henriksen I. B., Pace G. W., Mishra A. K. Rapid expansion from supercritical to aqueous solution to produce submicron suspensions of water‐insoluble drugs. Biotechnol. Prog. 2000; 16: 402–407, [CSA]
   PubMed Web of Science ®Google Scholar
• Henrikson I. B., Mishra A. K., Pace G. W., Johnston K. P., Mawson S. Insoluble Drug Delivery. 1997, WO9714407
   Google Scholar
• Pace G. W., Vachon M. G., Mishra A. K., Henrikson I. B., Krukonis V. Processes to Generate Submicron Particles of Water‐Insoluble Compounds. U.S. Patent 6,177,103, 2001
   Google Scholar
• Briggs A. R., Maxwell T. J. Process for Preparing Powder Blends. U.S. Patent 3,721,725, 1973
   Google Scholar
• Briggs A. R., Maxwell T. J. Lyophilized Biological Products. U.S. Patent 3,928,566, 1975
   Google Scholar
• Briggs A. R., Maxwell T. J. Method of Preparation of Lyophilized Biological Products. U.S. Patent 3,932,943, 1976
   Google Scholar
• Dunn D. B., Masavage G. J., Sauer H. A. Method of Freezing Solution Droplets and the Like Using Immiscible Refrigerants of Differing Densities. U.S. Patent 3,653,222, 1972
   Google Scholar
• Buxton I. R., Peach J. M. Process and Apparatus for Freezing a Liquid Medium. U.S. Patent 4,470,202, 1984
   Google Scholar
• Sauer H. A. Method and Apparatus for Freeze–Freeze Drying. U.S. Patent 3,484,946, 1969
   Google Scholar
• Adams T. H., Beck J. P., Menson R. C. Method and Apparatus for Making Novel Particulate Composition. U.S. Patent 4,211,015, 1980
   Google Scholar
• Adams T. H., Beck J. P., Menson R. C. Novel Particulate Composition. U.S. Patent 4,323,478, 1982
   Google Scholar
• Costantino H. R., Firouzabadian L., Hogeland K., Wu C., Beganski C., Carrasquillo K. G., Córdova M., Griebenow K., Zale S. E., Tracy M. A. Protein Spray‐Freeze Drying. Effect of Atomization Conditions on Particle Size and Stability. Pharm. Res. 2000; 17: 1374–1383
   PubMed Web of Science ®Google Scholar
• Costantino H. R., Firouzabadian L., Wu C., Carrasquillo K. G., Griebenow K., Zale S. E., Tracy M. A. Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. J. Pharm. Sci. 2002; 91: 388–395
   PubMed Web of Science ®Google Scholar
• Maa Y. F., Nguyen P. A., Sweeney T., Shire S. J., Hsu C. C. Protein inhalation powders‐spray drying vs. spray freeze drying. Pharm. Res. 1999; 16: 249–254
   PubMed Web of Science ®Google Scholar
• Maa Y. F., Prestrelski S. J. Biopharmaceutical powders: particle formation and formulation considerations. Curr. Pharm. Biotechnol. 2000; 1: 283–302, [CSA]
   PubMedGoogle Scholar
• Gombotz W. R., Healy M. S., Brown L. R., Auer H. E. Process for Producing Small Particles of Biologically Active Molecules. U.S. Patent 5019400, 1990
   Google Scholar
• Gombotz W. R., Healy H. S., Brown L. R. Very Low Temperature Casting of Controlled Release Microspheres. 1991, WO 90/13285
   Google Scholar
• Gombotz W. R., Pankey S. C., Phan D., Drager R., Donaldson K., Antonsen K. P., Hoffman A. S., Raff H. V., Howard V. The stabilization of a human IgM monoclonal antibody with poly(vinylpyrrolidone). Pharm. Res. 1994; 11: 624–632
   PubMed Web of Science ®Google Scholar
• Gusman M. I., Johnson S. M. Cryochemical Method of Preparing Ultrafine Particles of High‐Purity Superconducting Oxides. U.S. Patent 4,975,415, 1990
   Google Scholar
• Williams R. O., Hu J., Rogers T. L., Barron M. K., Young T. J., Yu Z., Johnston K. P. Process for Production of Nanoparticles and Microparticles by Spray Freezing into Liquid. U.S. Patent 20030041602, 2003
   Google Scholar
• Hu J., Johnston K. P., Williams R. O.I. Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent vs. aqueous‐organic co‐solvent systems. Eur. J. Pharm. Sci. 2003; 20: 295–303, [CSA]
   PubMed Web of Science ®Google Scholar
• Hu J., Johnston K. P., Williams R. O. Rapid dissolving high potency danazol powders produced by spray freezing into liquid (SFL) process with organic solvents. Int. J. Pharm. 2003, in press
   PubMedGoogle Scholar
• Rogers T. L., Hu J., Yu Z., Johnston K. P., Williams R. O. A novel particle engineering technology: spray‐freezing into liquid. Int. J. Pharm. 2002; 242: 93–100
   PubMed Web of Science ®Google Scholar
• Rogers T. L., Nelsen A. C., Hu J., Brown J. N., Sarkari M., Young T. J., Johnston K. P., Williams R. O. A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray‐freezing into liquid. Eur. J. Pharm. Biopharm. 2002; 54: 271–280, [CSA]
   PubMed Web of Science ®Google Scholar
• Rogers T. L., Nelsen A. C., Sarkari M., Young T., Johnston K. P., Williams R. O. Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray‐freezing into liquid with atmospheric freeze‐drying. Pharm. Res. 2003; 20: 485–493
   PubMed Web of Science ®Google Scholar
• Rogers T. L., Overhoff K. A., Shah P., Santiago P., Yacaman M. J., Johnston K. P., Williams R. O. Micronized powders of a poorly water soluble drug produced by a spray‐freezing into liquid‐emulsion process. Eur. J. Pharm. Biopharm. 2003; 55: 167–172
   Google Scholar
• Yu Z., Rogers T. L., Hu J., Johnston K. P., Williams R. O. Preparation and characterization of microparticles containing peptide produced by novel process: spray freezing into liquid. Eur. J. Pharm. Biopharm. 2002; 54: 221–228, [CSA]
   PubMed Web of Science ®Google Scholar
• Chen X., Young T. J., Sarkari M., Williams R. O., Johnston K. P. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. Int. J. Pharm. 2002; 242: 3–14
   PubMed Web of Science ®Google Scholar
• Sarkari M., Brown J. N., Chen X., Swinnea S., Williams R. O., Johnston K. P. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int. J. Pharm. 2002; 243: 17–31
   PubMed Web of Science ®Google Scholar
• Chen X., Williams R. O., Johnston K. P. Rapid dissolution of high potency danazol particles produced by evaporative precipitation into aqueous solution. J. Pharm. Sci. 2003, in press
   Web of Science ®Google Scholar